Which agents are FDA approved for thrombolytic therapy of pulmonary embolism (PE)?

Updated: Dec 31, 2017
  • Author: Wanda L Rivera-Bou, MD, FAAEM, FACEP; Chief Editor: Erik D Schraga, MD  more...
  • Print
Answer

Answer

The three thrombolytic agents currently approved by the FDA for use in patients with acute PE are alteplase, urokinase, and streptokinase. Tenecteplase is currently being studied for use in PE; however, it is not yet approved for this indication. [35]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!